BRAZIL POTASH CORP (GRO) Fundamental Analysis & Valuation

NYSEARCA:GRO • CA10586A1084

Current stock price

3.67 USD
+0.38 (+11.55%)
At close:
3.6698 USD
0 (-0.01%)
After Hours:

This GRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GRO Profitability Analysis

1.1 Basic Checks

  • In the past year GRO has reported negative net income.
  • GRO had a negative operating cash flow in the past year.
  • GRO had negative earnings in each of the past 5 years.
  • In the past 5 years GRO always reported negative operating cash flow.
GRO Yearly Net Income VS EBIT VS OCF VS FCFGRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • GRO has a worse Return On Assets (-43.92%) than 93.98% of its industry peers.
  • The Return On Equity of GRO (-45.29%) is worse than 80.72% of its industry peers.
Industry RankSector Rank
ROA -43.92%
ROE -45.29%
ROIC N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRO Yearly ROA, ROE, ROICGRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • GRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GRO Yearly Profit, Operating, Gross MarginsGRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. GRO Health Analysis

2.1 Basic Checks

  • GRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GRO Yearly Shares OutstandingGRO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GRO Yearly Total Debt VS Total AssetsGRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 23.35 indicates that GRO is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of GRO (23.35) is better than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that GRO is not too dependend on debt financing.
  • GRO has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GRO outperforms 96.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.35
ROIC/WACCN/A
WACCN/A
GRO Yearly LT Debt VS Equity VS FCFGRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 5.87 indicates that GRO has no problem at all paying its short term obligations.
  • GRO's Current ratio of 5.87 is amongst the best of the industry. GRO outperforms 95.18% of its industry peers.
  • A Quick Ratio of 5.87 indicates that GRO has no problem at all paying its short term obligations.
  • GRO has a better Quick ratio (5.87) than 95.18% of its industry peers.
Industry RankSector Rank
Current Ratio 5.87
Quick Ratio 5.87
GRO Yearly Current Assets VS Current LiabilitesGRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. GRO Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -21.24% on average over the next years. This is quite bad
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y63.87%
EPS Next 2Y28.65%
EPS Next 3Y18.68%
EPS Next 5Y-21.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRO Yearly Revenue VS EstimatesGRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 2032 200M 400M 600M 800M 1B
GRO Yearly EPS VS EstimatesGRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. GRO Valuation Analysis

4.1 Price/Earnings Ratio

  • GRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRO Price Earnings VS Forward Price EarningsGRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRO Per share dataGRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • GRO's earnings are expected to grow with 18.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.65%
EPS Next 3Y18.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRO Dividend Analysis

5.1 Amount

  • GRO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRO Fundamentals: All Metrics, Ratios and Statistics

BRAZIL POTASH CORP

NYSEARCA:GRO (4/2/2026, 8:04:00 PM)

After market: 3.6698 0 (-0.01%)

3.67

+0.38 (+11.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-23
Earnings (Next)N/A
Inst Owners20.34%
Inst Owner Change719%
Ins Owners4.95%
Ins Owner ChangeN/A
Market Cap195.87M
Revenue(TTM)N/A
Net Income(TTM)-66.61M
Analysts80
Price Target6.29 (71.39%)
Short Float %0.71%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-346.43%
Min EPS beat(2)-382.67%
Max EPS beat(2)-310.18%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)89.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS2.76
TBVpS2.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.92%
ROE -45.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.87
Quick Ratio 5.87
Altman-Z 23.35
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y63.87%
EPS Next 2Y28.65%
EPS Next 3Y18.68%
EPS Next 5Y-21.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-249.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40.14%
EBIT Next 3Y14.43%
EBIT Next 5Y4.52%
FCF growth 1Y-24.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.56%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZIL POTASH CORP / GRO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRAZIL POTASH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to GRO.


What is the valuation status of BRAZIL POTASH CORP (GRO) stock?

ChartMill assigns a valuation rating of 0 / 10 to BRAZIL POTASH CORP (GRO). This can be considered as Overvalued.


How profitable is BRAZIL POTASH CORP (GRO) stock?

BRAZIL POTASH CORP (GRO) has a profitability rating of 0 / 10.


Can you provide the financial health for GRO stock?

The financial health rating of BRAZIL POTASH CORP (GRO) is 6 / 10.